Form 4: Lemaitre Vascular Director Acquires Shares via PSU Vesting

Sentiment:

Insider Transaction Report


Lemaitre Vascular Director Lawrence J. Jasinski acquired common stock through performance share unit settlement and dividend equivalent rights.

Summary

  • Lawrence J. Jasinski, a Director at Lemaitre Vascular Inc. (LMAT), acquired 476 shares of common stock on February 26, 2026.
  • These shares were acquired upon the settlement of a Performance Share Unit (PSU) award granted on December 6, 2024, with 1/3 vesting upon satisfaction of a performance condition.
  • An additional 1 share of common stock was acquired on February 26, 2026, upon the release of dividend equivalent rights (DERs) associated with the PSU award.
  • Each dividend equivalent right is economically equivalent to one share of the Issuer's common stock.
  • Following these transactions, Mr. Jasinski beneficially owns 5,799 shares of Lemaitre Vascular Inc. common stock directly.

Sentiment

Score: 7

Explanation: StockSavvy.ai views this as a moderately positive event, reflecting the successful achievement of performance conditions and strengthening insider ownership, which aligns management incentives with shareholder interests.

Positives

  • The vesting of Performance Share Units indicates that specific performance conditions set by the company have been met.
  • Director acquisition of shares, even through awards, aligns management's interests with those of shareholders.

Future Outlook

The balance of the Performance Share Unit award is scheduled to vest in equal annual installments on the grant date anniversary over the next two years.

Industry Context

StockSavvy.ai notes that insider transactions, particularly acquisitions stemming from performance-based compensation, are generally viewed positively as they demonstrate management's continued alignment with the company's long-term success and shareholder value creation within the medical device industry.

Stakeholder Impact

  • Shareholders: Increased alignment of director's interests with shareholder value through performance-based equity compensation.

Next Steps

  • Remaining PSU installments will vest in equal annual installments on the grant date anniversary over the next two years.

Key Dates

DateDescription
12/06/2024Grant date of the Performance Share Unit (PSU) award.
02/26/2026Transaction date for the acquisition of common stock from PSU settlement and dividend equivalent rights release.
03/02/2026Signature date of the reporting person's attorney-in-fact.

Recommendation

hold

The filing details a routine insider acquisition of shares through performance-based compensation, which is a positive for management alignment but typically not a standalone catalyst for a strong buy or sell recommendation. It reinforces a 'hold' stance, indicating stable governance and compensation practices.

Keywords

LMAT, Lemaitre Vascular, Form 4, Insider Transaction, Stock Acquisition, Performance Share Unit, PSU, Dividend Equivalent Rights, Director Compensation

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.